Old Web
English
Sign In
Acemap
>
authorDetail
>
Richelle Linklater
Richelle Linklater
Peter MacCallum Cancer Centre
Ipilimumab
Nivolumab
Oncology
Medicine
Internal medicine
4
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Ipilimumab and nivolumab in patients with rare gynaecological malignancies: Results of an Australian, multi-centre, phase 2 trial (CA209-538)
2021
Asia-pacific Journal of Clinical Oncology
Damien Kee
Oliver Klein
Bo Gao
Ben Markman
Jessica Da Gama Duarte
Luke T. Quigley
Louise Jackettt
Linda Mileshkin
Richelle Linklater
Jodie Palmer
Clare L. Scott
Clare Matteo Carlino
Andreas Behren
Jonathan Cebon
Show All
Source
Cite
Save
Citations (0)
Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial.
2021
Journal for ImmunoTherapy of Cancer
Oliver Klein
Damien Kee
Bo Gao
Ben Markman
Jessica Da Gama Duarte
Luke Quigley
Louise Jackett
Richelle Linklater
Andrew Strickland
Clare L. Scott
Linda Mileshkin
Jodie Palmer
Matteo S. Carlino
Andreas Behren
Jonathan Cebon
Show All
Source
Cite
Save
Citations (0)
Combination immunotherapy with ipilimumab and nivolumab in patients with rare gynaecological malignancies.
2020
Journal of Clinical Oncology
Oliver Klein
Damien Kee
Bo Gao
Ben Markman
Linda Mileshkin
Clare L. Scott
Yeojeong Jane So
Richelle Linklater
Andreas Behren
Jodie Palmer
Matteo S. Carlino
Jonathan Cebon
Show All
Source
Cite
Save
Citations (2)
A phase II clinical trial of ipilimumab/nivolumab combination immunotherapy in patients with rare upper gastrointestinal, neuroendocrine, and gynecological malignancies.
2019
Journal of Clinical Oncology
Oliver Klein
Damien Kee
Ben Markman
Rachael Chang Lee
Michael Michael
Linda Mileshkin
Clare L. Scott
Richelle Linklater
Sid Menon
Niall C. Tebbutt
Jodie Palmer
Andreas Behren
Jonathan Cebon
Show All
Source
Cite
Save
Citations (1)
1
map